255 related articles for article (PubMed ID: 22844109)
1. Associations between microRNA expression and mesenchymal marker gene expression in glioblastoma.
Ma X; Yoshimoto K; Guan Y; Hata N; Mizoguchi M; Sagata N; Murata H; Kuga D; Amano T; Nakamizo A; Sasaki T
Neuro Oncol; 2012 Sep; 14(9):1153-62. PubMed ID: 22844109
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-138 suppresses glioblastoma proliferation through downregulation of CD44.
Yeh M; Wang YY; Yoo JY; Oh C; Otani Y; Kang JM; Park ES; Kim E; Chung S; Jeon YJ; Calin GA; Kaur B; Zhao Z; Lee TJ
Sci Rep; 2021 Apr; 11(1):9219. PubMed ID: 33911148
[TBL] [Abstract][Full Text] [Related]
3. Detection of proneural/mesenchymal marker expression in glioblastoma: temporospatial dynamics and association with chromatin-modifying gene expression.
Murata H; Yoshimoto K; Hatae R; Akagi Y; Mizoguchi M; Hata N; Kuga D; Nakamizo A; Amano T; Sayama T; Iihara K
J Neurooncol; 2015 Oct; 125(1):33-41. PubMed ID: 26272600
[TBL] [Abstract][Full Text] [Related]
4. Simultaneous miRNA and mRNA transcriptome profiling of glioblastoma samples reveals a novel set of OncomiR candidates and their target genes.
Gulluoglu S; Tuysuz EC; Sahin M; Kuskucu A; Kaan Yaltirik C; Ture U; Kucukkaraduman B; Akbar MW; Gure AO; Bayrak OF; Dalan AB
Brain Res; 2018 Dec; 1700():199-210. PubMed ID: 30176243
[TBL] [Abstract][Full Text] [Related]
5. MiR-373/miR-520s-CD44 Axis Significantly Inhibits the Growth and Invasion of Human Glioblastoma Cells.
Feng S; Wang K; Shao Z; Lin Q; Li B; Liu P
Arch Med Res; 2022 Sep; 53(6):550-561. PubMed ID: 36115716
[TBL] [Abstract][Full Text] [Related]
6. A three-microRNA signature identifies two subtypes of glioblastoma patients with different clinical outcomes.
Marziali G; Buccarelli M; Giuliani A; Ilari R; Grande S; Palma A; D'Alessandris QG; Martini M; Biffoni M; Pallini R; Ricci-Vitiani L
Mol Oncol; 2017 Sep; 11(9):1115-1129. PubMed ID: 28248456
[TBL] [Abstract][Full Text] [Related]
7. A restricted signature of serum miRNAs distinguishes glioblastoma from lower grade gliomas.
Regazzo G; Terrenato I; Spagnuolo M; Carosi M; Cognetti G; Cicchillitti L; Sperati F; Villani V; Carapella C; Piaggio G; Pelosi A; Rizzo MG
J Exp Clin Cancer Res; 2016 Jul; 35(1):124. PubMed ID: 27476114
[TBL] [Abstract][Full Text] [Related]
8. High miR-196a and low miR-367 cooperatively correlate with unfavorable prognosis of high-grade glioma.
Guan Y; Chen L; Bao Y; Qiu B; Pang C; Cui R; Wang Y
Int J Clin Exp Pathol; 2015; 8(6):6576-88. PubMed ID: 26261539
[TBL] [Abstract][Full Text] [Related]
9. Bioinformatic analyses reveal a distinct Notch activation induced by STAT3 phosphorylation in the mesenchymal subtype of glioblastoma.
Cheng W; Zhang C; Ren X; Jiang Y; Han S; Liu Y; Cai J; Li M; Wang K; Liu Y; Hu H; Li Q; Yang P; Bao Z; Wu A
J Neurosurg; 2017 Jan; 126(1):249-259. PubMed ID: 26967788
[TBL] [Abstract][Full Text] [Related]
10. Profiling of novel circulating microRNAs as a non-invasive biomarker in diagnosis and follow-up of high and low-grade gliomas.
Tabibkhooei A; Izadpanahi M; Arab A; Zare-Mirzaei A; Minaeian S; Rostami A; Mohsenian A
Clin Neurol Neurosurg; 2020 Mar; 190():105652. PubMed ID: 31896490
[TBL] [Abstract][Full Text] [Related]
11. PI3 kinase pathway regulated miRNome in glioblastoma: identification of miR-326 as a tumour suppressor miRNA.
Nawaz Z; Patil V; Paul Y; Hegde AS; Arivazhagan A; Santosh V; Somasundaram K
Mol Cancer; 2016 Nov; 15(1):74. PubMed ID: 27871300
[TBL] [Abstract][Full Text] [Related]
12. Analysis of miR-9-5p, miR-124-3p, miR-21-5p, miR-138-5p, and miR-1-3p in Glioblastoma Cell Lines and Extracellular Vesicles.
Zottel A; Šamec N; Kump A; Raspor Dall'Olio LR; Pužar Dominkuš P; Romih R; Hudoklin S; Mlakar J; Nikitin D; Sorokin M; Buzdin A; Jovčevska I; Komel R
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33187334
[TBL] [Abstract][Full Text] [Related]
13. MiRNA expression profiling in human gliomas: upregulated miR-363 increases cell survival and proliferation.
Conti A; Romeo SG; Cama A; La Torre D; Barresi V; Pezzino G; Tomasello C; Cardali S; Angileri FF; Polito F; Ferlazzo G; Di Giorgio R; Germanò A; Aguennouz M
Tumour Biol; 2016 Oct; 37(10):14035-14048. PubMed ID: 27495233
[TBL] [Abstract][Full Text] [Related]
14. Oncostatin-M differentially regulates mesenchymal and proneural signature genes in gliomas via STAT3 signaling.
Natesh K; Bhosale D; Desai A; Chandrika G; Pujari R; Jagtap J; Chugh A; Ranade D; Shastry P
Neoplasia; 2015 Feb; 17(2):225-37. PubMed ID: 25748242
[TBL] [Abstract][Full Text] [Related]
15. Uncovering MicroRNA and Transcription Factor Mediated Regulatory Networks in Glioblastoma.
Sun J; Gong X; Purow B; Zhao Z
PLoS Comput Biol; 2012; 8(7):e1002488. PubMed ID: 22829753
[TBL] [Abstract][Full Text] [Related]
16. miR-504 suppresses mesenchymal phenotype of glioblastoma by directly targeting the FZD7-mediated Wnt-β-catenin pathway.
Liu Q; Guan Y; Li Z; Wang Y; Liu Y; Cui R; Wang Y
J Exp Clin Cancer Res; 2019 Aug; 38(1):358. PubMed ID: 31419987
[TBL] [Abstract][Full Text] [Related]
17. Estimating survival time of patients with glioblastoma multiforme and characterization of the identified microRNA signatures.
Yerukala Sathipati S; Huang HL; Ho SY
BMC Genomics; 2016 Dec; 17(Suppl 13):1022. PubMed ID: 28155650
[TBL] [Abstract][Full Text] [Related]
18. Identifying dysfunctional miRNA-mRNA regulatory modules by inverse activation, cofunction, and high interconnection of target genes: a case study of glioblastoma.
Xiao Y; Ping Y; Fan H; Xu C; Guan J; Zhao H; Li Y; Lv Y; Jin Y; Wang L; Li X
Neuro Oncol; 2013 Jul; 15(7):818-28. PubMed ID: 23516263
[TBL] [Abstract][Full Text] [Related]
19. Dysregulated miR-671-5p / CDR1-AS / CDR1 / VSNL1 axis is involved in glioblastoma multiforme.
Barbagallo D; Condorelli A; Ragusa M; Salito L; Sammito M; Banelli B; Caltabiano R; Barbagallo G; Zappalà A; Battaglia R; Cirnigliaro M; Lanzafame S; Vasquez E; Parenti R; Cicirata F; Di Pietro C; Romani M; Purrello M
Oncotarget; 2016 Jan; 7(4):4746-59. PubMed ID: 26683098
[TBL] [Abstract][Full Text] [Related]
20. Hypoxia-inducible miR-196a modulates glioblastoma cell proliferation and migration through complex regulation of NRAS.
Takkar S; Sharma V; Ghosh S; Suri A; Sarkar C; Kulshreshtha R
Cell Oncol (Dordr); 2021 Apr; 44(2):433-451. PubMed ID: 33469841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]